References
- 1. G. Bjørklund, P. Oliinyk, R. Lysiuk, M. S. Rahaman, H. Antonyak, I. Lozynska, L. Lenchyk and M. Peana, Arsenic intoxication: general aspects and chelating agents, Arch. Toxicol.94 (2020) 1879–1897; https://doi.org/10.1007/s00204-020-02739-w10.1007/s00204-020-02739-w721046332388818
- 2. M. K. Lawson, M. Valko, M. T. D. Cronin and K. Jomová, Chelators in iron and copper toxicity, Curr. Pharmacol. Rep.2 (2016) 271–280; https://doi.org/10.1007/s40495-016-0068-810.1007/s40495-016-0068-8
- 3. M. Abou Chakra, A. E. Dellis, A. G. Papatsoris and M. Moussa, Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium, Expert Opin. Pharmacother.21 (2020) 85–96; https://doi.org/10.1080/14656566.2019.168597910.1080/14656566.2019.168597931714803
- 4. M. S. C. Morgan and M. S. Pearle, Medical management of renal stones, BMJ352 (2016) Article ID i52; https://doi.org/10.1136/bmj.i5210.1136/bmj.i5226977089
- 5. K. Aquilano, S. Baldelli and M. R. Ciriolo, Glutathione: New roles in redox signaling for an old antioxidant, Front. Pharmacol. 5 (2014) Article ID 196; https://doi.org/10.3389/fphar.2014.0019610.3389/fphar.2014.00196414409225206336
- 6. Y. Honda, T. Kessoku, Y. Sumida, T. Kobayashi, T. Kato, Y. Ogawa, W. Tomeno, K. Imajo, K. Fujita, M. Yoneda, K. Kataoka, M. Taguri, T. Yamanaka, Y. Seko, S. Tanaka, S. Saito, M. Ono, S. Oeda, Y. Eguchi, W. Aoi, K. Sato, Y. Itoh and A. Nakajima, Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: An open-label, single-arm, multicenter, pilot study, BMC Gastroenterol.17 (2017) Article ID 96 (8 pages); https://doi.org/10.1186/s12876-017-0652-310.1186/s12876-017-0652-3554943128789631
- 7. S. Weschawalit, S. Thongthip, P. Phutrakool and P. Asawanonda, Glutathione and its antiaging and antimelanogenic effects, Clin. Cosmet. Investig. Dermatol.10 (2017) 147–153; https://doi.org/10.2147/ccid.s12833910.2147/CCID.S128339541347928490897
- 8. British Pharmacopoeia, The Stationery Office, London 2009.
- 9. L. Litao, L. Jing, and L. Quanmin, A novel method for the determination of tiopronin by using potassium ferricyanide as spectroscopic probe reagent in pharmaceutical and urine samples, J. Anal. Chem.67 (2012) 41–46; https://doi.org/10.1134/s106193481201009110.1134/S1061934812010091
- 10. M. Skowron and W. Ciesielski, Spectrophotometric determination of methimazole, d-penicilla-mine, captopril, and disulfiram in pure form and drug formulations, J. Anal. Chem.66 (2011) 714–719; https://doi.org/10.1134/s106193481108013210.1134/S1061934811080132
- 11. L. Kukoc-Modun and N. Radic, Spectrophotometric determination of N-acetyl-l-cysteine and N-(2-mercaptopropionyl)-glycine in pharmaceutical preparations, Int. J. Anal. Chem. 2011 (2011) Article ID 140756; https://doi.org/10.1155/2011/14075610.1155/2011/140756310384521647283
- 12. Q. Li and L. Gao, Spectrophotometric determination of tiopronin using its catalytic reaction between sodium 1,2-naphthoquinone-4-sulfonate and hydroxyl ion, Anal. Sci.25 (2009) 89–93; https://doi.org/10.2116/analsci.25.8910.2116/analsci.25.89
- 13. A. A. Al-Majed, Spectrophotometric estimation of D-penicillamine in bulk and dosage forms using 2,6-dichloroquinone-4-chlorimide (DCQ), J. Pharm. Biomed. Anal.21 (1999) 827–833; https://doi.org/10.1016/s0731-7085(99)00215-010.1016/S0731-7085(99)00215-0
- 14. M. A. Raggi, L. Nobile and A. G. Giovannini, Spectrophotometric determination of glutathione and of its oxidation product in pharmaceutical dosage forms, J. Pharm. Biomed. Anal.9 (1991) 1037–1040; https://doi.org/10.1016/0731-7085(91)80041-710.1016/0731-7085(91)80041-7
- 15. A. Besada, N. B. Tadros and Y. A. Gawargious, Copper(II)-neocuproine as colour reagent for some biologically active thiols: Spectrophotometric determination of cysteine, penicillamine, glutathione, and 6-mercaptopurine, Mikrochim. Acta99 (1989) 143–146; https://doi.org/10.1007/bf0124280010.1007/BF01242800
- 16. Y. H. Chen, F. S. Tian and G. F. Zhang, High-sensitivity spectrofluorimetric determination of tiopronin based on inhibition of hemoglobin, Luminescence26 (2011) 477–480; https://doi.org/10.1002/bio.125510.1002/bio.1255
- 17. J. Xu, R. Cai, J. Wang, Z. Liu and X. Wu, Fluorometric assay of tiopronin based on inhibition of multienzyme redox system, J. Pharm. Biomed. Anal.39 (2005) 334–338; https://doi.org/10.1016/j.jpba.2005.03.00410.1016/j.jpba.2005.03.004
- 18. S. M. Al-Ghannam, A. M. El-Brashy and B. S. Al-Farhan, Fluorimetric determination of some thiol compounds in their dosage forms, Farmaco57 (2002) 625–629; https://doi.org/10.1016/s0014-827x(02)01223-510.1016/S0014-827X(02)01223-5
- 19. A. A. Al-Majed, Specific spectrofluorometric quantification of D-penicillamine in bulk and dosage forms after derivatization with 4-fluoro-7-nitrobenzo-2-oxa-1,3-diazole, Anal. Chim. Acta408 (2000) 169–175; https://doi.org/10.1016/s0003-2670(99)00869-710.1016/S0003-2670(99)00869-7
- 20. J. A. Murillo Pulgarín, J. M. Lemus Gallego and M. N. Sánchez García, Determination of tiopronin in pharmaceutical preparations by time resolved chemiluminescence using the stopped-flow technique, Anal. Lett.46 (2013) 1836–1848; https://doi.org/10.1080/00032719.2012.73530510.1080/00032719.2012.735305
- 21. F. E. O. Suliman, M. M. Al-Hinai, S. M. Z. Al-Kindy and S. B. Salama, Enhancement of the chemiluminescence of penicillamine and ephedrine after derivatization with aldehydes using tris(bipyridyl) ruthenium(II) peroxydisulfate system and its analytical application, Talanta74 (2008) 1256–1264; https://doi.org/10.1016/j.talanta.2007.08.04010.1016/j.talanta.2007.08.04018371778
- 22. J. Lu, C. Lau, S. Yagisawa, K. Ohta and M. Kai, A simple and sensitive chemiluminescence method for the determination of tiopronin for a pharmaceutical formulation, J. Pharm. Biomed. Anal.33 (2003) 1033–1038; https://doi.org/10.1016/s0731-7085(03)00413-810.1016/S0731-7085(03)00413-8
- 23. J. B. Raoof, R. Ojani, M. Majidian and F. Chekin, Homogeneous electrocatalytic oxidation of D-penicillamine with ferrocyanide at a carbon paste electrode: Application to voltammetric determination, J. Appl. Electrochem.39 (2009) 799–805; https://doi.org/10.1007/s10800-008-9724-y10.1007/s10800-008-9724-y
- 24. J. B. Raoof, R. Ojani and F. Chekin, Electrochemical oxidation of 4-chlorocatechol in the presence of some sulphydryl compounds: Applications to voltammetric detection of d-penicillamine, glutathione and l-cysteine, Anal. Bioanal. Electrochem.1 (2009) 200–215; https://www.researchgate.net/publication/279705715
- 25. A. A. J. Torriero, H. D. Piola, N. A. Martínez, N. V. Panini, J. Raba and J. J. Silber, Enzymatic oxidation of tert-butylcatechol in the presence of sulfhydryl compounds: Application to the amperometric detection of penicillamine, Talanta71 (2007) 1198–1204; https://doi.org/10.1016/j.talanta.2006.06.02710.1016/j.talanta.2006.06.027
- 26. A. Martinović and N. Radić, Kinetic potentiometric determination of some thiols with iodide ion-sensitive electrode, Anal. Lett.40 (2007) 2851–2859; https://doi.org/10.1080/0003271070160388410.1080/00032710701603884
- 27. L. Kukoc-Modun and N. Radić, Potentiometric determination of N-(2-Mercaptopropionyl)-glycine using an electrode with AgI-based membrane, Croat. Chem. Acta79 (2006) 533–539.
- 28. R. M. Soliman, G. M. Hadad, R. A. Abdel Salam and M. K. Mesbah, Quantitative determination of glutathione in presence of its degradant in a pharmaceutical preparation using HPLC-DAD and identification by LC-ESI-MS, J. Liq. Chromatogr. Relat. Technol.37 (2014) 548–559; https://doi.org/10.1080/10826076.2012.74949710.1080/10826076.2012.749497
- 29. V. Sutariya, D. Wehrung and W. J. Geldenhuys, Development and validation of a novel RP-HPLC method for the analysis of reduced glutathione, J. Chromatogr. Sci.50 (2012) 271–276; https://doi.org/10.1093/chromsci/bmr05510.1093/chromsci/bmr055
- 30. L. Manna, L. Valvo and P. Betto, Determination of oxidized and reduced glutathione in pharmaceuticals by reversed-phase high-performance liquid chromatography with dual electrochemical detection, J. Chromatogr. A846 (1999) 59–64; https://doi.org/10.1016/s0021-9673(99)00427-610.1016/S0021-9673(99)00427-6
- 31. A. Martinović-Bevanda and N. Radić, Spectrophotometric sequential injection determination of D-penicillamine based on a complexation reaction with nickel ion, Anal. Sci.29 (2013) 669–671; https://doi.org/10.2116/analsci.29.66910.2116/analsci.29.66923749136
- 32. T. D. Karakosta and P. D. Tzanavaras, Automated derivatization of pharmaceutically active thiols under flow conditions using an o-phthalaldehyde/glycine fluorogenic system and sequential injection analysis, Anal. Lett.44 (2011) 2530–2542; https://doi.org/10.1080/00032719.2011.55186210.1080/00032719.2011.551862
- 33. L. Kukoc-Modun and N. Radić, Flow-injection spectrophotometric determination of tiopronin based on coupled redox-complexation reaction, Chem. Anal. (Warsaw) 54 (2009) 871–882; https://www.bib.irb.hr/395955
- 34. F. E. O. Suliman, Z. H. Al-Lawati and S. M. Z. Al-Kindy, A spectrofluorimetric sequential injection method for the determination of penicillamine using fluorescamine in the presence of β-cyclodextrins, J. Fluoresc.18 (2008) 1131–1138; https://doi.org/10.1007/s10895-008-0363-910.1007/s10895-008-0363-918496741
- 35. B. G. T. Corominas, J. Pferzschner, M. C. Icardo, L. L. Zamora and J. M. Calatayud, In situ generation of Co(II) by use of a solid-phase reactor in an FIA assembly for the spectrophotometric determination of penicillamine, J. Pharm. Biomed. Anal.39 (2005) 281–284; https://doi.org/10.1016/j.jpba.2005.02.04410.1016/j.jpba.2005.02.044
- 36. A. Agarwal, S. Prasad and R. M. Naik, Inhibitory kinetic spectrophotometric method for the quantitative estimation of D-penicillamine at micro levels, Microchem. J.128 (2016) 181–186; https://doi.org/10.1016/j.microc.2016.04.00510.1016/j.microc.2016.04.005
- 37. R. M. Naik, S. Prasad, B. Kumar and V. Chand, Kinetic assay of D-penicillamine in pure and pharmaceutical formulations based on ligand substitution reaction, Microchem. J.111 (2013) 97–102; https://doi.org/10.1016/j.microc.2012.07.01510.1016/j.microc.2012.07.015
- 38. M. I. Walash, A. M. El-Brashy, M. S. Metwally and A. A. Abdelal, Spectrophotometric and kinetic determination of some sulphur containing drugs in bulk and drug formulations, Bull. Korean Chem. Soc.25 (2004) 517–524; https://doi.org/10.5012/bkcs.2004.25.4.51710.5012/bkcs.2004.25.4.517
- 39. M. I. Walash, M. E. S. Metwally, A. M. El-Brashy and A. A. Abdelal, Kinetic spectrophotometric determination of some sulfur containing compounds in pharmaceutical preparations and human serum, Farmaco58 (2003) 1325–1332; https://doi.org/10.1016/s0014-827x(03)00167-810.1016/S0014-827X(03)00167-8
- 40. A. Martinović, L. Kukoc-Modun and N. Radić, Kinetic spectrophotometric determination of thiols and ascorbic acid, Anal. Lett.40 (2007) 805–815; https://doi.org/10.1080/0003271060101793810.1080/00032710601017938
- 41. L. Kukoc-Modun and N. Radić, Novel kinetic spectrophotometric method for determination of tiopronin [N-(2-mercaptopropionyl)-glycine], Croat. Chem. Acta83 (2010) 189–195.
- 42. L. Kukoc-Modun and N. Radic, Kinetic spectrophotometric determination of N-acetyl-l-cysteine based on a coupled redox-complexation reaction, Anal. Sci.26 (2010) 491–495; https://doi.org/10.2116/analsci.26.49110.2116/analsci.26.49120410574
- 43. N. Radić, L. Kukoc-Modun and M. Biocic, Kinetic spectrophotometric determination of N-acetyl- - l-cysteine based on the reduction of copper(II)-neocuproine reagent, Croat. Chem. Acta86 (2013) 65–71; https://doi.org/10.5562/cca216110.5562/cca2161
- 44. C. J. Hawkins and D. D. Perrin, Oxidation–reduction potentials of metal complexes in water. Part II. Copper complexes with 2,9-dimethyl- and 2-chloro-1,10-phenanthroline, J. Chem. Soc. (1963) 2996–3002; https://doi.org/10.1039/jr963000299610.1039/JR9630002996